Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., L...

FDA Recall #D-0279-2025 — Class II — March 7, 2025

Recall #D-0279-2025 Date: March 7, 2025 Classification: Class II Status: Ongoing

Product Description

Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 43215, Mfg. by: Piramal Pharma Limited, Madhya Pradesh, India, NDC 70436-008-04

Reason for Recall

CGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.

Recalling Firm

Slate Run Pharmaceuticals — Columbus, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,444 bottles

Distribution

Product was distributed to 8 distributors who may have further distribute the product nationwide.

Code Information

Lot # 109797, Exp 11/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated